MDCX
Medicus Pharma Ltd.
Key Financials
Operating Income
$-34359302
↓ 207.3%
Net Income
$-47281513
↓ 323.8%
Cash & Equivalents
$8.7M
↑ 109.0%
EPS (Diluted)
$-2.74
↓ 136.2%
Total Assets
$10.1M
↑ 78.2%
Shareholders' Equity
$-67554.00
↓ 102.2%
Total Liabilities
$10.0M
↑ 299.0%
Operating Cash Flow
$-22776769.00
↓ 122.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 424B3 | 6/4/2026 | View on SEC |
| 8-K | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MDCX |
| Company Name | Medicus Pharma Ltd. |
| CIK | 1997296 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A6 |
| Phone | 610-540-7515 |